Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Neonatal polycythemia

INTRODUCTION

Neonatal polycythemia is characterized by a venous hematocrit (hct) that greatly exceeds normal values for gestational and postnatal age. This condition affects approximately 1 to 5 percent of newborns. Although many affected infants are asymptomatic, the characteristic clinical features are thought to result from hyperviscosity and/or the metabolic effects of an increased red blood cell mass.

DEFINITION

Polycythemia — Polycythemia is defined as a hematocrit (hct) or hemoglobin concentration that is greater than two standard deviations (SD) above the normal value for gestational and postnatal age [1]. Accordingly, a term infant is considered to be polycythemic if the hct from a peripheral venous sample is greater than 65 percent or the hemoglobin is greater than 22 g/dL [2-5]. In clinical circumstances, the definition typically is based upon the hct, rather than the hemoglobin concentration.

The diagnosis of polycythemia is based upon peripheral venous samples because of the variability in measurements obtained from capillary samples. Hctss of blood from venous samples may be as much as 15 percent lower than those obtained from capillary samples. In one study of newborns with peripheral venous hcts ≥65 percent, the mean values for capillary, peripheral venous, and umbilical venous hcts were 75, 71, and 63 percent, respectively [6].

In neonates, initial screening tests are often obtained via capillary sampling (heel stick). The mean hct and hemoglobin concentrations from these capillary samples in normal term infants at birth are 61 ± 7.4 (SD) percent and 19.3 ± 2.2 g/dL (SD), respectively [1]. These values reflect an increased red cell mass as compared with older infants and children, which is caused by the fetal response of increased hemoglobin production to a relatively hypoxic intrauterine environment and possibly vasomotor instability and venous pooling in newborn immediately after birth. Polycythemia is suspected when the screening hct and hemoglobin greatly exceed these values, and is diagnosed only if the elevated hct or hemoglobin is confirmed in a venous sample.

Hyperviscosity — Polycythemia must be distinguished from hyperviscosity, which is defined as a blood viscosity greater than 12 centipoise, measured at a shear rate of 11.5 per second; or greater than 6 centipoise, measured at a shear rate of 106 per second [7]. Whole blood viscosity can be affected by significant increases in any of the elements of whole blood including red cells, white cells, platelets, plasma proteins, immunoglobulins or clotting factors. In neonates, the focus is generally on red cell excess [8].

                        

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Oct 2014. | This topic last updated: Sep 17, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Luchtman-Jones L, Wilson DB. Hematologic problems in the fetus and neonate. In: Neonatal-Perinatal Medicine, 9, Martin RJ, Fanaroff AA, Walsh MC (Eds), Elsevier Mosby, St. Louis 2011. p.1303.
  2. Oski FA, Naiman JL. Polycythemia and hyperviscosity in the neonatal period. In: Hematologic Problems in the Newborn, 3 ed, Oski FA (Ed), WB Saunders, New York 1982. p.87.
  3. Wiswell TE, Cornish JD, Northam RS. Neonatal polycythemia: frequency of clinical manifestations and other associated findings. Pediatrics 1986; 78:26.
  4. Stevens K, Wirth FH. Incidence of neonatal hyperviscosity at sea level. J Pediatr 1980; 97:118.
  5. Ramamurthy, RS. Neonatal polycythemia and hyperviscosity; state of the art. Perinatology-Neonatology 1979; 3:38.
  6. Ramamurthy RS, Brans YW. Neonatal polycythemia: I. Criteria for diagnosis and treatment. Pediatrics 1981; 68:168.
  7. Swetnam SM, Yabek SM, Alverson DC. Hemodynamic consequences of neonatal polycythemia. J Pediatr 1987; 110:443.
  8. Lowe GD. Rheological influences on thrombosis. Baillieres Best Pract Res Clin Haematol 1999; 12:435.
  9. Gross GP, Hathaway WE, McGaughey HR. Hyperviscosity in the neonate. J Pediatr 1973; 82:1004.
  10. Drew JH, Guaran RL, Grauer S, Hobbs JB. Cord whole blood hyperviscosity: measurement, definition, incidence and clinical features. J Paediatr Child Health 1991; 27:363.
  11. Brooks GI, Backes CR. Hyperviscosity secondary to polycythemia in the appropriate for gestational age neonate. J Am Osteopath Assoc 1981; 80:415.
  12. Rawlings JS, Pettett G, Wiswell TE, Clapper J. Estimated blood volumes in polycythemic neonates as a function of birth weight. J Pediatr 1982; 101:594.
  13. Mentzer WC, Glader BE. Erythrocyte disorders in infancy. In: Avery's Diseases of the Newborn, 7 ed, Taeusch HW, Ballard RA (Eds), WB Saunders, Philadelphia 1998. p.1080.
  14. Capasso L, Raimondi F, Capasso A, et al. Early cord clamping protects at-risk neonates from polycythemia. Biol Neonate 2003; 83:197.
  15. Shohat M, Reisner SH, Mimouni F, Merlob P. Neonatal polycythemia: II. Definition related to time of sampling. Pediatrics 1984; 73:11.
  16. Ramamurthy RS, Berlanga M. Postnatal alteration in hematocrit and viscosity in normal and polycythemic infants. J Pediatr 1987; 110:929.
  17. Villalta IA, Pramanik AK, Diaz-Blanco J, Herbst JJ. Diagnostic errors in neonatal polycythemia based on method of hematocrit determination. J Pediatr 1989; 115:460.
  18. Wirth FH, Goldberg KE, Lubchenco LO. Neonatal hyperviscosity: I. Incidence. Pediatrics 1979; 63:833.
  19. Rosenkrantz TS, Stonestreet BS, Hansen NB, et al. Cerebral blood flow in the newborn lamb with polycythemia and hyperviscosity. J Pediatr 1984; 104:276.
  20. Strauss RG, Mock DM, Johnson K, et al. Circulating RBC volume, measured with biotinylated RBCs, is superior to the Hct to document the hematologic effects of delayed versus immediate umbilical cord clamping in preterm neonates. Transfusion 2003; 43:1168.
  21. Hutton EK, Hassan ES. Late vs early clamping of the umbilical cord in full-term neonates: systematic review and meta-analysis of controlled trials. JAMA 2007; 297:1241.
  22. McDonald SJ, Middleton P, Dowswell T, Morris PS. Effect of timing of umbilical cord clamping of term infants on maternal and neonatal outcomes. Cochrane Database Syst Rev 2013; 7:CD004074.
  23. MICHAEL AF Jr, MAUER AM. Maternal-fetal transfusion as a cause of plethora in the neonatal period. Pediatrics 1961; 28:458.
  24. GOLD AP, MICHAEL AF Jr. Congenital adrenal hyperplasia associated with polycythemia. Pediatrics 1959; 23:727.
  25. Weinblatt ME, Fort P, Kochen J, DiMayio M. Polycythemia in hypothyroid infants. Am J Dis Child 1987; 141:1121.
  26. Bussmann YL, Tillman ML, Pagliara AS. Neonatal thyrotoxicosis associated with the hyperviscosity syndrome. J Pediatr 1977; 90:266.
  27. Mentzer WC. Polycythaemia and the hyperviscosity syndrome in newborn infants. Clin Haematol 1978; 7:63.
  28. Black VD, Lubchenco LO, Koops BL, et al. Neonatal hyperviscosity: randomized study of effect of partial plasma exchange transfusion on long-term outcome. Pediatrics 1985; 75:1048.
  29. Black VD, Lubchenco LO, Luckey DW, et al. Developmental and neurologic sequelae of neonatal hyperviscosity syndrome. Pediatrics 1982; 69:426.
  30. Malan AF, de V Heese H. The management of polycythaemia in the newborn infant. Early Hum Dev 1980; 4:393.
  31. Goldberg K, Wirth FH, Hathaway WE, et al. Neonatal hyperviscosity. II. Effect of partial plasma exchange transfusion. Pediatrics 1982; 69:419.
  32. Katz J, Rodriguez E, Mandani G, Branson HE. Normal coagulation findings, thrombocytopenia, and peripheral hemoconcentration in neonatal polycythemia. J Pediatr 1982; 101:99.
  33. Phibbs RH. Neonatal polycythemia. In: Rudolph's Pediatrics, 20 ed, Rudolph AM (Ed), Appleton & Lange, Stamford, CT 1996. p.252.
  34. Black VD, Lubchenco LO. Neonatal polycythemia and hyperviscosity. Pediatr Clin North Am 1982; 29:1137.
  35. Bada HS, Korones SB, Pourcyrous M, et al. Asymptomatic syndrome of polycythemic hyperviscosity: effect of partial plasma exchange transfusion. J Pediatr 1992; 120:579.
  36. Schimmel MS, Bromiker R, Soll RF. Neonatal polycythemia: is partial exchange transfusion justified? Clin Perinatol 2004; 31:545.
  37. American Academy of Pediatrics Committee on Fetus and Newborn: Routine evaluation of blood pressure, hematocrit, and glucose in newborns. Pediatrics 1993; 92:474.
  38. Mimouni FB, Merlob P, Dollberg S, et al. Neonatal polycythaemia: critical review and a consensus statement of the Israeli Neonatology Association. Acta Paediatr 2011; 100:1290.
  39. Sankar MJ, Agarwal R, Deorari A, Paul VK. Management of polycythemia in neonates. Indian J Pediatr 2010; 77:1117.
  40. Acunas B, Celtik C, Vatansever U, Karasalihoglu S. Thrombocytopenia: an important indicator for the application of partial exchange transfusion in polycythemic newborn infants? Pediatr Int 2000; 42:343.
  41. Kumar A, Ramji S. Effect of partial exchange transfusion in asymptomatic polycythemic LBW babies. Indian Pediatr 2004; 41:366.
  42. Rosenkrantz TS, Oh W. Cerebral blood flow velocity in infants with polycythemia and hyperviscosity: effects of partial exchange transfusion with Plasmanate. J Pediatr 1982; 101:94.
  43. Bada HS, Korones SB, Kolni HW, et al. Partial plasma exchange transfusion improves cerebral hemodynamics in symptomatic neonatal polycythemia. Am J Med Sci 1986; 291:157.
  44. Maertzdorf WJ, Tangelder GJ, Slaaf DW, Blanco CE. Effects of partial plasma exchange transfusion on cerebral blood flow velocity in polycythaemic preterm, term and small for date newborn infants. Eur J Pediatr 1989; 148:774.
  45. Ergenekon E, Hirfanoglu IM, Turan O, et al. Partial exchange transfusion results in increased cerebral oxygenation and faster peripheral microcirculation in newborns with polycythemia. Acta Paediatr 2011; 100:1432.
  46. Murphy DJ Jr, Reller MD, Meyer RA, Kaplan S. Effects of neonatal polycythemia and partial exchange transfusion on cardiac function: an echocardiographic study. Pediatrics 1985; 76:909.
  47. de Waal KA, Baerts W, Offringa M. Systematic review of the optimal fluid for dilutional exchange transfusion in neonatal polycythaemia. Arch Dis Child Fetal Neonatal Ed 2006; 91:F7.
  48. Dempsey EM, Barrington K. Crystalloid or colloid for partial exchange transfusion in neonatal polycythemia: a systematic review and meta-analysis. Acta Paediatr 2005; 94:1650.
  49. Black VD, Rumack CM, Lubchenco LO, Koops BL. Gastrointestinal injury in polycythemic term infants. Pediatrics 1985; 76:225.
  50. Hein HA, Lathrop SS. Partial exchange transfusion in term, polycythemic neonates: absence of association with severe gastrointestinal injury. Pediatrics 1987; 80:75.
  51. Delaney-Black V, Camp BW, Lubchenco LO, et al. Neonatal hyperviscosity association with lower achievement and IQ scores at school age. Pediatrics 1989; 83:662.
  52. Dempsey EM, Barrington K. Short and long term outcomes following partial exchange transfusion in the polycythaemic newborn: a systematic review. Arch Dis Child Fetal Neonatal Ed 2006; 91:F2.
  53. Ozek E, Soll R, Schimmel MS. Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia. Cochrane Database Syst Rev 2010; :CD005089.